23 HIV-Associated Neurocognitive Disorders (HAND) affect over half of HIV-infected individuals 24 worldwide, despite antiretroviral therapy (ART). Therapeutically targetable mechanisms 25 underlying HAND remain elusive. We developed a human-induced pluripotent stem cell (HiPSC) 26 based model; whereby, we independently differentiate HiPSCs into neurons, astrocytes, and 27 microglia and systematically combine to generate a tri-culture with or without HIV-infection and 28 ART. scRNAseq analysis on tri-cultures including HIV-infected microglia revealed inflammatory 29 signatures in the microglia and EIF2 signaling in all three cell types. Remarkably, EFZ alone 30 induced a similar response to infection. Treatment with the antiretroviral compound Efavirenz 31 (EFZ) mostly resolved these signatures; However, EFZ increased RhoGDI and CD40 signaling in 32 the HIV-infected microglia. This activation was associated with a persistent increase in TNFa 33 expression. This work establishes a tri-culture that recapitulates key features of HIV infection in 34 the CNS and provides a new model to examine the effects of HIV infection and its treatment with 35 antiretrovirals. 36
Introduction 37
HIV-Associated Neurocognitive Disorders (HAND) are a chronic, progressing spectrum of 38 diseases that lead to a range of neurologic disorders, including HIV-associated dementia. The 39 major pathologic manifestation that persists in HAND patients with antiretroviral treatment 40 (ART) is synaptodendritic damage and the accumulation of microglia, the immune cell in the 41 central nervous system (CNS); however, the mechanisms underlying synaptic damage remain 42 elusive. Synapse loss is associated with infiltration of macrophages from outside of the CNS and 43 activation of microglia. Both HIV-infected macrophage populations can release cytokines, viral 44 proteins, and excitotoxins, which can lead to synaptic damage (Saylor et al., 2016) . Activated 45 microglia aberrantly phagocytosing synapses have been described in multiple neurological 46 experience milder forms of HAND, they still experience chronic inflammation (Kolson, 2017) . 49 Infected microglia and uninfected, but active microglia may be working in tandem to slowly 50 release proinflammatory cytokines and reactive oxygen species that, over time, can lead to 51 synaptodendritic damage. 52
Inflammation, via various pathways, plays a large role in the neurodegeneration seen in 53 persisted exclusively in the iNrns in the Inf+EFZ condition. While infection lead to increased 95 inflammation in the iMg, it also led to decreased synaptophagy. EFZ treatment in infected 96 cultures did not reverse the phagocytosis impairment but did quell the inflammation except for 97 distinct gene activation of CD40 and RhoGDI signaling in the iMg. Lastly EFZ treatment itself lead 98 to a very similar response as Inf. Our system has reveals the complex roles of the individual cell 99 types during infection ± ART and how ART alone can elicit an inflammatory response. 
iMicroglia exhibit similar gene and protein expression as other iPSC-derived microglia 114
We modified two previously published protocols to generate the iMg (Abud et al., 2017; 115 Paluru et al., 2014) ( Figure 1a ). The first step is a nine-day differentiation of iPSCs into 116 CD41+CD235+ common myeloid progenitors (CMPs) (Paluru et al., 2014) . The second step is a 117 modified 11-day protocol (Abud et al., 2017 ) that produces a highly pure population of iMg. We 118 tested this protocol on four separate cell lines. These iMg show ramification (Figure 1-figure  119 supplement 1a), express several classical markers, including: CX3CR1, IBA1, and P2RY12, at the 120 protein and RNA level (Figures 1b and 1c ) in mono-culture, and have a significantly different gene 121 expression profile than monocyte-derived macrophages (MDMs) (Figure 1-figure supplement  122 1b). We validated the findings in BulkRNAseq with qRT-PCR. The iMg exhibited a 179-fold, 28-123 fold, and 11-fold increase in CX3CR1, P2RY12, and TMEM119 respectively over MDMs (Figure 1d -124 1f). Importantly they also express CCR5 (Figure 1-figure supplement 1c) , one of the co-receptors 125 necessary for HIV infection (Deng et al., 1996) . Utilizing PCA, we compared our iMg to human 126
MDMs we generated and the primary human adult and fetal microglia, iPSCs, induced 127 hematopoietic progenitor cells, and iMicroglia from (Abud et al., 2017) . PCA revealed considerate 128 clustering of our iMg (pink) to the primary human microglia (blue) and previously published iPSC-129 derived microglia (light orange) ( Figure 1g 
iMg Are productively infected with HIV and respond to multiple antiretrovirals 144
We investigated the effects of HIV infection and ART in an iMg mono-culture. We first 145 determined infectivity of the iMg. We exposed the iMg to 50ng/mL of the CSF-derived, R5-tropic 146 supplement 2c and 2d). Therefore, we excluded it from all future analysis. To our knowledge, this 155 this the first time iPSC-derived microglia have been infected with HIV. 156
We tested two antiretroviral treatments that target different parts of the HIV life cycle, 157 Darunavir (DRN) and efavirenz (EFZ) ( Figure 2-figure supplement 2a ). DRN is a protease inhibitor 158 that prevents assembly of new virus (Wood & Flexner, 1998) , and EFZ is a non-nucleoside reverse 159 transcriptase inhibitor that prevents reverse transcription of the viral genome (De Clercq, 2004) . 160
We opted to focus on EFZ, as it is still a first line drug in many parts of the world (Best &  161 Goicoechea, 2008; Taramasso et al., 2018), Further, because it blocks HIV infection at the reverse 162 transcription phase, we can study non-productively infected, HIV-exposed cells alongside 163 productively infected cells.. Importantly, the infected iMg responded as expected to EFZ ( We also explored the changes in cytokine production over the course of infection ± EFZ. 172
Infection led to increased production of several pro-inflammatory cytokines, specifically IL-1b, IL-173 1a, TNFa, and most prominently, IL-8 ( Figures 2f-2i ). However, the two other cytokines tested: IL-174 6 and IL-10, did not change across any condition (Figure 2-figure supplement 3a-3c). IL-8 175 production was increased in cultured, infected, fetal microglia (Tatro, Soontornniyomkij, 176 Letendre, & Achim, 2014), and IL-1b RNA was increased in laser-captured microglia from brain 177 samples of HIV-infected patients (Ginsberg et al., 2018) . Infected iMg cultures exposed to EFZ 178 had mitigated, non-significant responses to IL-1b, IL-8, TNFa, and IL-1a ( Figures 2f-2i ), suggesting 179 a reduced inflammatory reaction. Uninf, Uninf+EFZ and the DMSO vehicle control did not 180 elucidate a cytokine reaction across the six cytokines tested ( We also exposed the iAst in mono-culture to the most highly expressed cytokines in the 247 HIV-infected iMg, to determine if the cytokines produced by infected iMg can elicit an 248 inflammatory response in the iAst. We exposed the iAst to IL-1b and IL-8 at 10ng/mL for eight 249 hours and then analyzed the supernatants on the same six-cytokine panel. We found that, of the 250 six cytokines tested, the iAst produced increased amounts of IL-1a (Figure 2-figure supplement 251 5b), suggesting that the iMicroglia can elicit an inflammatory response in the iAst. In addition, it 252 is interesting that IL-1a was released given its role in producing A1 astrocytes (Liddelow et al., 253 2017) . 254
255
The HiPSC-derived tri-culture is sustainable with iAst and iMg derived from novel 256 differentiation protocols 257
In order to study the cell-cell interactions during HIV infection and subsequent 258 antiretroviral treatment (ART), we developed a novel tri-culture system of HiPSC-derived 259 microglia (iMg), neurons (iNrn), and astrocytes (iAst) by separately differentiating each cell type, 260 infecting the iMg (± ART), then co-plating the different populations into a carpet culture for 261 analysis. The tri-culture is able to survive for at least 2 weeks ( Figure 3f Next, we studied the cell types' reactions in a more physiologically relevant tri-culture. To 272 create the tri-culture, we began the iNrn differentiation, added the iAst at D5 of the iNrn 273 differentiation, after the Ara-C had been removed, and added the iMg at D7 of the iNrn 274 differentiation. The tri-culture was maintained for an additional 14 days, to D21 of the iNrn 275 differentiation (Figure 4a ). To assay gene expression changes in each of the three cell types during 276 HIV infection ± EFZ, we conducted scRNAseq on the tri-culture under four conditions: Uninf, Inf, 277
Inf+EFZ, and Uninf+EFZ (Figure 4a ). Cells were sequenced from the Uninf (n=6,564), Inf (n=7,431), 278
Inf+EFZ (n=7,111), and Uninf+ EFZ (n=10,071) conditions. All conditions were then aggregated 279 and initially analyzed through the cellranger pipeline (10x Genomics, v.3.0.1). Secondary analysis 280 was performed using the Seurat package in R. We generated 16 unbiased clusters ( Figure 4b ). 281
First, we separated the clusters by cell type, then broke down each cell cluster by condition. We 282 assigned clusters to one of the three cell types by expression of several key genes: iMg by 283 expression of IBA1, PU.1, and CD4; iNrn by expression of MAP2 and SYN1; and iAst by expression 284 of THBS1 and SOX9 (Figures 4c-4e ). There were four clusters (cluster 5, 10, 12, and 13) that did 285 not fit into any of the three cell types by expression of the chosen markers ( Figure 4b responses not only across conditions, but also across cell types within conditions. These data 405 reveal a potential downside to pre-emptive ART use and suggest that the inflammatory response 406 from Infected to Inf+EFZ to Uninf+EFZ is not a linear regression as one might expect, but rather 407 three distinct responses. We further investigated these gene pathway changes by testing for 408 cytokine production and phagocytic abilities. In order to determine their ability to phagocytose synapses, we generated tri-culture of 436 the iMg with the iNrn and iAst and examined them 14 days after adding the iMg (Figure 4a ). The 437 cultures were subjected to immunofluorescence for IBA1, the lysosomal marker LAMP1, and the 438 pre-synaptic marker SYN1. We found colocalization of SYN1 in the LAMP1+ lysosomes of the iMg 439 ( Figure 8a and 8b ), suggesting that the iMg phagocytize synaptic material. We confirmed that 440 iMg are in contact with iNrns ( Figure 8c ), and importantly, only the iMg are infected as only they, 441
and not the iNrns (Figure 8d ) or iAstrocytes, show P24 immunofluorescence. Additionally, RT 442 activity confirmed that the iMg in the infected condition remain productively infected (Figure 9a ). 443
We were also able to delineate infected from uninfected iMg in the Inf+EFZ condition by multi-444 nucleation (Figures 2c, 2d , and Figure 8-figure supplement 1a) . 445
We utilized confocal imaging and 3D reconstruction to measure the total synaptic volume, 446 as indicated by synaptophysin immunofluorescence, within the iMg. The Inf iMg showed reduced 447 synaptophagocytosis compared to Uninf iMg. In addition, in the Inf+EFZ condition, the infected 448 (multinucleated) have reduced phagocytosis; however, the uninfected (single-nucleated) iMg in 449 the Inf+EFZ condition trended lower but was not statistically significant. Lastly, Uninf+EFZ 450 condition iMg also had impaired synaptophagocytosis (Figure 8e To confirm that differences in apparent iMg synaptophagy are not secondary to reduced 462 numbers of synapses overall in a given culture condition, we also measured local and random (50 463 µm radius areas with no iMg) synapse density to ensure the uninfected microglia were not in a 464 more synapse dense area (Figure 8-figure supplement 2a and 2b) . In fact, there was no significant 465 difference in iMg-proximal or random synapse density across all conditions (Figure 8 
478 EFZ reduces the production of IL-8 and IL-1b by infected iMg, but enhances TNFa 479
Lastly, we compared cytokine production between each condition in tri-culture. Starting 480 at the time of iMg addition, we collected supernatant every 5 days until day 14 of tri-culture. IL-481 8 and IL-1b were significantly increased in the infected tri-culture compared to uninfected 482 control. IL-1b remained increased over uninfected; however, IL-8 decreases by day 10 (Figure 9b  483 and 9c). Unlike in mono-culture, the Inf+EFZ condition had reduced cytokine production of IL-8 484 and IL-1b compared to uninfected. Uninf+EFZ had the lowest levels of cytokine production across 485 all the groups (Figure 9b-9d ). In addition, there was no increase in TNFa in the Inf tri-culture; 486 however, the Inf+EFZ condition did have increased TNFa (Figure 9d ). The Inf and Inf+EFZ tri-487 cultures also did not exhibit increases in IL-6 or IL-10, similar to our mono-culture findings ( Figure  488 2- figure supplement 3c and 3d) . These data combined with the scRNA data suggest there are 489 distinct influences on the inflammatory response during infection alone and infection with EFZ. 490 iMg in the Inf condition exclusively had increased expression of IL-8 and IL-1b genes (Figure 5c) . 491
In addition, IL-8 and NF-κB signaling were activated only in iMg in the Inf condition by scRNAseq 492 (Figure 6b We were also able to show that the microglia seem to be the main culprit in the initial 512 response to HIV infection; however, at least within the two-week period of this study, iMg 513 infection does not lead to aberrant phagocytosis of synapses. This falls in line with previously 514 reported impaired phagocytosis by HIV-infected or exposed macrophage (Debaisieux et al., 2015; 515 Mazzolini et al., 2010) . With Nef and Tat targeting early stages of the phagocytosis, and most of 516 the genes dysregulated in the Fcγ receptor-mediated phagocytosis target early endocytosis, it is 517 likely that the increased pathway activation is a compensation mechanism. Infection with 518
HIVΔNef could confirm this. 519
In addition, we discovered a starkly different immune response at the gene and functional 520 level in Inf versus Inf+EFZ. CD40 and RhoGDI activation could be controlled by the increased 521 production of TNFa, that was only found in the Inf+EFZ condition. This persistent immune 522 activation highlights the need for further studies into the role that antiretrovirals play in 523
propagating the chronic inflammation seen in HIV patients today (Kolson, 2017; Saylor et al., 524 2016 ). The mitigated reaction we observed with EFZ treatment is consistent with human studies 525 showing a reduced severity of HAND with the widespread use of antiretroviral therapies (Saylor 526 et al., 2016) , but also with its persistence despite control of viral load. Further, we revealed a 527 substantial immune response to EFZ treatment alone. This warrants further study as people take 528 ART as a preventative measure (Spinner et al., 2016) . 529
HiPSC cultures are particularly useful for studying HIV neuropathology, since human 530 primary neuronal cells and postmortem tissue are limited in availability and not amenable to 531 molecular manipulation. In addition, HIV only infects human cells, rendering the interpretation 532 of results from animal models more convoluted. Hence, mechanistic studies of the influences of 533 HIV and ART on human neural cells are limited. This tri-culture system allows us to better study 534 the mechanisms of early HIV infection in the brain; however, there are caveats to this system 535 that must be considered. Each of the iPSC-derived cell types are similar to their in vivo 536 counterparts by gene and protein expression, as well as, function, but are not exact. In addition, 537 the iCells' gene expression profile at the end stage of differentiation is relatively immature and 538 more closely represents early stages of development in vivo. Our culture system allows 539 reductionist study of three key cell types over weeks but may be refined by inclusion of additional 540 cell types, and further optimization to model HAND in the adult setting. 541
This tri-culture has validated several findings in the field as well as produced multiple novel 542 findings for HIV neuropathology. However, this model is not restricted to HIV neuropathology 543 and can also be utilized to study other neurological disorders. This highly tractable, reductive 544 system can be genetically and pharmacologically modified at any stage. These differentiations 545 could also be used on patient-derived cells, creating a disease-relevant, patient-specific tri- packaged by the University of Pennsylvania Viral Vector Core. Cells were exposed to 1ug/mL 562 polybrene (Sigma Aldrich TR-1003). Media is fully exchanged six hours after exposure. iPSCs are 563 differentiated according to a previously published method (Zhang et al., 2013) . In brief, after 564 transfection, iPSCs were exposed to N2 media containing 5 mL N2 Supplement-B (Stemcell 565
Technologies 07156), 0.5mL 55mM β-mercaptoethanol (Life technologies 21985-023), 0.5mL 566 primocin (Invivogen ant-pm-2), BDNF (10ng/mL, peprotech 450-02), NT-3 (10ng/mL, peprotech 567 450-03), laminin (200ng/mL, Sigma L2020), and doxycycline (2ug/mL, Sigma D3072) in DMEM / 568 F12 (Gibco 11320-033) for 24 hours (DIV0). Cells were then exposed to puromycin (5ug/mL, 569 Sigma P9620) for 24 hours in the same N2 media (DIV1). iNeurons were re-plated 24 hours later 570 (DIV2) to experiment appropriate plates coated with Matrigel GFR (Corning 354230). Cells were 571 washed 2x in PBS and lifted with StemPro accutase (Thermo Fisher Scientific A11105-01) for 5min 572 at 37°C. Cells were spun down at 1000RPM for 5min at RT. Cells were resuspended and plated 573 in iN media (Neurobasal-A media (Invitrogen A24775-01) with 5mM glucose (Sigma G5146), 574 10mM sodium pyruvate (Sigma P5280), glutamax (Life Technologies 35050-061), 575 penicillin/streptomycin (Thermo Fisher Scientific 15140-148), BDNF and NT-3 (10ng/mL), and 576 doxycycline (2ug/mL) through 9 days. 2µM Ara-C (Sigma C6645) was added on DIV3, and there 577 was a full media exchange 24 hours later (DIV4). Doxycycline post DIV10 was discontinued for 578 the rest of the 21-day differentiation. 579 iAstrocyte differentiation of iPSCs 581 iPSCs transfected with the NGN2 virus were put through the first two days of the iNeuron 582 differentiation. On day 3, cells were exposed to Astrocyte differentiation media: N2 media 583 (without BDNF, NT-3, laminin, and doxycycline), 10% FBS (Hyclone SH30071.03HI) Human TGF-β1 (50ng/mL, Peprotech 100-21). Half media changes were performed every two 598 days for 11 days. 599 600 Tri-culture combination 601 iNeurons were differentiated as described above and re-plated on DIV2 to Matrigel (Corning 602 354230) coated Nunc Lab-Tek II 8-well chamber slides (Thermo Fisher Scientific 62407-296) at 603 70k cells/well in iN media. On DIV5 of iNeuron differentiation, the iAstrocytes were added at 50k 604 cells/well. On DIV7 of iNeuron differentiation, iMicroglia were added at 100k cell/well. Cultures 605 were taken out to DIV21 of iNeuron differentiation. Of note, this preparation creates a "carpet-606 culture" of the three cell types that is roughly 50um thick 607 608
Human astrocytes 609
Three separate donors for human astrocytes were obtained from Sciencell. Cells were plated on 610 PLL-coated plates (Sigma Aldrich P6282) and grown for two weeks in Astrocyte media (Sciencell 611 1801) and then RNA was extracted. 612 613 iAstrocyte cytokine exposure 614 iAstrocytes in mono-culture were exposed to IL-1b (R&D Systems 201-LB-005) or IL-8 (R&D 615
Systems 208-IL-010) at 10ng/mL or PBS vehicle control for 8 hours. Supernatants were collected 616 and sent for cytokine analysis. 617
618

HIV infection 619
iMicroglia were differentiated to D11. On D11, they were exposed to 50ng/mL of JAGO strain HIV 620 
Monocyte-derived macrophage differentiation 626
We receive donated buffy coat from New York Blood Center from three donors (D471, D446, 627 D470). Buffy coat was diluted 1:1 with PBS (without Ca 2+ and Mg 2+ ) (Invitrogen 14190144). 15 628 mLs of Ficoll (Sigma Aldrich 26878-85-8) was added to 50mL conical tubes. 25mLs of Buffy 629
Coat/PBS was slowly layered onto the Ficoll. Samples were spun at 1200 rpm for 45 minutes with 630 no brake. The peripheral blood mononuclear cell (PBMC) layer was removed and placed into a 631 new 50mL conical tube, and the volume was brought up to 50mL with PBS. The PBMCs are spun 632 at 450Xg for 10 minutes. The supernatant was discarded, and the pellet resuspended in 10mLs 633
of Red Blood Cell Lysis buffer (Sigma Aldrich 11814389001). Cells were shaking at RT for 10 634 minutes. Volume was brought up to 50mLs in PBS and spun at 450Xg for 10minutes. The 635 supernatant was discarded, and the pellet was resuspended in DMEM with 10% FBS + Gentamicin 636 (Thermo Fisher Scientific 15750060). The PBMCs were plated on 6-well tissue culture plate for 5 637 circle. The area of the cell and the area of the particles were subtracted from the total area of 696 the circle and the total particles. The remaining total area of the particles was divided by the 697 remaining total area of the circle to calculate local synapse density. 698 699 Bulk RNA-seq 700 RNA was extracted using previously described with RNeasy mini kit (Qiagen 74104) and frozen at 701 -80°C. Samples were sent to the Center for Applied Genomics (CAG) for sequencing. In short, the 702
Illumina TruSeq Stranded Total RNA library kit (Illumina RS-122-2201) for RNA-seq was utilized 703 for preparation of the libraries for sequencing. Libraries were produced using liquid handler 704 automation with the PerkinElmer Sciclone instrument. This procedure started with a ribosomal 705 RNA (rRNA) depletion step. The depletion step uses target-specific oligos with specialized rRNA 706 removal beads to remove both cytoplasmic and mitochondrial rRNA from the total 707 RNA. Following this purification, the RNA was fragmented using a brief, high-temperature 708 incubation. The fragmented RNA was then reverse transcribed into first-strand cDNA using 709 reverse transcriptase and random primers. Second strand cDNA was generated using DNA 710
Polymerase which was then used in a standard TruSeq Illumina-adapter based library 711 preparation. Library preparation consisted of four main steps: unique adapter-indexes were 712 ligated to the RNA fragments, AmpureXP bead purification occurred to remove small library 713 fragments, the libraries were enriched and amplified using PCR, and the libraries underwent a 714 final purification using AmpureXP beads. Upon completion, library quality was assessed using an 715 automated electrophoresis instrument, the PerkinElmer Labchip GX Touch, and qPCR using the Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate 801 containing protease inhibitors, including 1 mg/ml leupeptin, 250 mM phenylmethylsulfonyl 802 fluoride, 1 mg/ml aprotinin, and 1 mM iodoacetamide) for 1 hour while rotating on a shaker at 803 4 o C. Cortical and hippocampal tissue was harvested from adult C57BL/6 mice and solubilized in 804 5 volumes of homogenization buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-805 40, 1% SDS, containing protease and phosphatase inhibitors, including 1 mg/ml leupeptin, 806 250 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, 1 mM iodoacetamide, 10mM NaF, 807 30mM Na pyrophosphate, 1mM Na 3 VO 4 ). All lysates were centrifuged at 17,000g for 20 min to 808 remove cellular debris and nuclei. The supernatants were analyzed for total protein using the 809 Pierce protein assay kit according to the manufacturer's instructions. Lysates are diluted 1:1 with 810 2X Laemmli buffer and either boiled at 95 o C for 5 min (GFAP, Actin) or kept at 25 o C for 45 minutes 811 (GLAST, GLT-1, EAAC1). iAst lysates (20ug) or cortical/hippocampal lysates (5ug) were then 812 resolved by SDS PAGE using 10% BioRad minigels and transferred to Immobilon-FL membranes 813 (Millipore Cat# IPFL00010). Membranes were incubated with blocking buffer (1% non-fat dry 814 milk in TBS-T) for 1 hour at 25 o C prior to probing with primary antibodies diluted in blocking 815 buffer overnight at 4 o C: rabbit anti-GLT-1 (C-terminal directed 1:5,000; Rothstein et al 1994), 816 mouse anti-GLAST (Miltenyi Biotec Cat# 130-095-822, 1:50), rabbit anti-EAAC1 (Santa Cruz Cat# 817 SC-25658, 1:50), mouse anti-GFAP (Cell Signaling Cat#3670S, 1:1,000), and mouse anti-Actin 818
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